Patents by Inventor Roslyn RAY

Roslyn RAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTISENSE RNA FOR TREATMENT OF SARS-ASSOCIATED CORONAVIRUS
    Publication number: 20230323353
    Abstract: Provided herein are, inter alia, nucleic acids (e.g., siRNA), lipid nanoparticles comprising nucleic acids, pharmaceutical compositions comprising nucleic acids, pharmaceutical compositions comprising lipid nanoparticles, and methods of treating COV-ID-19, SARS viruses, and Middle Eastern respiratory syndrome.
    Type: Application
    Filed: March 23, 2021
    Publication date: October 12, 2023
    Inventors: Kevin Morris, Tristan Scott, Roslyn Ray, Galina Shevchenko, Denis O'Meally
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
    Publication number: 20220275375
    Abstract: Provided herein are, inter alia, compositions and methods for the treatment of hypercholesterolemia. The compositions include double-stranded and single-stranded RNAs capable of repressing IncRNA and concomitantly increasing LDLR activation. The compositions are useful for activating LDLR in liver cells.
    Type: Application
    Filed: February 2, 2022
    Publication date: September 1, 2022
    Inventors: Kevin V. MORRIS, Roslyn RAY
  • Compositions and methods for the treatment of hypercholesterolemia
    Patent number: 11242531
    Abstract: Provided herein are, inter alia, compositions and methods for the treatment of hypercholesterolemia. The compositions include double-stranded and single-stranded RNAs capable of repressing IncRNA and concomitantly increasing LDLR activation. The compositions are useful for activating LDLR in liver cells.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: February 8, 2022
    Assignee: CITY OF HOPE
    Inventors: Kevin V. Morris, Roslyn Ray
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
    Publication number: 20200040343
    Abstract: Provided herein are, inter alia, compositions and methods for the treatment of hypercholesterolemia. The compositions include double-stranded and single-stranded RNAs capable of repressing IncRNA and concomitantly increasing LDLR activation. The compositions are useful for activating LDLR in liver cells.
    Type: Application
    Filed: February 2, 2018
    Publication date: February 6, 2020
    Inventors: Kevin V. MORRIS, Roslyn RAY